Skip to main navigation Skip to search Skip to main content

UB CAT: Evaluation of a new monoclonal antibody targeting immune-regulatory receptor CD5

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/22 → 06/30/22

Funding

  • Manhattan BioSolutions Incorporated: $9,600.00